Global Imatinib Mesylate Tablets Market Growth (Status and Outlook) 2023-2029

January 2023 | 88 pages | ID: G7CE309476DEEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Imatinib Mesylate Tablets Industry Forecast” looks at past sales and reviews total world Imatinib Mesylate Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Imatinib Mesylate Tablets sales for 2023 through 2029. With Imatinib Mesylate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Imatinib Mesylate Tablets industry.

This Insight Report provides a comprehensive analysis of the global Imatinib Mesylate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Imatinib Mesylate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Imatinib Mesylate Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Imatinib Mesylate Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Imatinib Mesylate Tablets.

The global Imatinib Mesylate Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Imatinib Mesylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Imatinib Mesylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Imatinib Mesylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Imatinib Mesylate Tablets players cover Teva Pharmaceuticals, Hikma Pharmaceuticals, Apotex Inc, Sun Pharmaceutical Industries, Lupin Limited, Natco Pharma and Getwell Oncology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Mesylate Tablets market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 100 mg
• 400 mg

Segmentation by application

• Hospital
• Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Teva Pharmaceuticals
• Hikma Pharmaceuticals
• Apotex Inc
• Sun Pharmaceutical Industries
• Lupin Limited
• Natco Pharma
• Getwell Oncology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Imatinib Mesylate Tablets Market Size 2018-2029
  2.1.2 Imatinib Mesylate Tablets Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Imatinib Mesylate Tablets Segment by Type
  2.2.1 100 mg
  2.2.2 400 mg
2.3 Imatinib Mesylate Tablets Market Size by Type
  2.3.1 Imatinib Mesylate Tablets Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
2.4 Imatinib Mesylate Tablets Segment by Application
  2.4.1 Hospital
  2.4.2 Clinics
2.5 Imatinib Mesylate Tablets Market Size by Application
  2.5.1 Imatinib Mesylate Tablets Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)

3 IMATINIB MESYLATE TABLETS MARKET SIZE BY PLAYER

3.1 Imatinib Mesylate Tablets Market Size Market Share by Players
  3.1.1 Global Imatinib Mesylate Tablets Revenue by Players (2018-2023)
  3.1.2 Global Imatinib Mesylate Tablets Revenue Market Share by Players (2018-2023)
3.2 Global Imatinib Mesylate Tablets Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IMATINIB MESYLATE TABLETS BY REGIONS

4.1 Imatinib Mesylate Tablets Market Size by Regions (2018-2023)
4.2 Americas Imatinib Mesylate Tablets Market Size Growth (2018-2023)
4.3 APAC Imatinib Mesylate Tablets Market Size Growth (2018-2023)
4.4 Europe Imatinib Mesylate Tablets Market Size Growth (2018-2023)
4.5 Middle East & Africa Imatinib Mesylate Tablets Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Imatinib Mesylate Tablets Market Size by Country (2018-2023)
5.2 Americas Imatinib Mesylate Tablets Market Size by Type (2018-2023)
5.3 Americas Imatinib Mesylate Tablets Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Imatinib Mesylate Tablets Market Size by Region (2018-2023)
6.2 APAC Imatinib Mesylate Tablets Market Size by Type (2018-2023)
6.3 APAC Imatinib Mesylate Tablets Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Imatinib Mesylate Tablets by Country (2018-2023)
7.2 Europe Imatinib Mesylate Tablets Market Size by Type (2018-2023)
7.3 Europe Imatinib Mesylate Tablets Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Imatinib Mesylate Tablets by Region (2018-2023)
8.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2018-2023)
8.3 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IMATINIB MESYLATE TABLETS MARKET FORECAST

10.1 Global Imatinib Mesylate Tablets Forecast by Regions (2024-2029)
  10.1.1 Global Imatinib Mesylate Tablets Forecast by Regions (2024-2029)
  10.1.2 Americas Imatinib Mesylate Tablets Forecast
  10.1.3 APAC Imatinib Mesylate Tablets Forecast
  10.1.4 Europe Imatinib Mesylate Tablets Forecast
  10.1.5 Middle East & Africa Imatinib Mesylate Tablets Forecast
10.2 Americas Imatinib Mesylate Tablets Forecast by Country (2024-2029)
  10.2.1 United States Imatinib Mesylate Tablets Market Forecast
  10.2.2 Canada Imatinib Mesylate Tablets Market Forecast
  10.2.3 Mexico Imatinib Mesylate Tablets Market Forecast
  10.2.4 Brazil Imatinib Mesylate Tablets Market Forecast
10.3 APAC Imatinib Mesylate Tablets Forecast by Region (2024-2029)
  10.3.1 China Imatinib Mesylate Tablets Market Forecast
  10.3.2 Japan Imatinib Mesylate Tablets Market Forecast
  10.3.3 Korea Imatinib Mesylate Tablets Market Forecast
  10.3.4 Southeast Asia Imatinib Mesylate Tablets Market Forecast
  10.3.5 India Imatinib Mesylate Tablets Market Forecast
  10.3.6 Australia Imatinib Mesylate Tablets Market Forecast
10.4 Europe Imatinib Mesylate Tablets Forecast by Country (2024-2029)
  10.4.1 Germany Imatinib Mesylate Tablets Market Forecast
  10.4.2 France Imatinib Mesylate Tablets Market Forecast
  10.4.3 UK Imatinib Mesylate Tablets Market Forecast
  10.4.4 Italy Imatinib Mesylate Tablets Market Forecast
  10.4.5 Russia Imatinib Mesylate Tablets Market Forecast
10.5 Middle East & Africa Imatinib Mesylate Tablets Forecast by Region (2024-2029)
  10.5.1 Egypt Imatinib Mesylate Tablets Market Forecast
  10.5.2 South Africa Imatinib Mesylate Tablets Market Forecast
  10.5.3 Israel Imatinib Mesylate Tablets Market Forecast
  10.5.4 Turkey Imatinib Mesylate Tablets Market Forecast
  10.5.5 GCC Countries Imatinib Mesylate Tablets Market Forecast
10.6 Global Imatinib Mesylate Tablets Forecast by Type (2024-2029)
10.7 Global Imatinib Mesylate Tablets Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Teva Pharmaceuticals
  11.1.1 Teva Pharmaceuticals Company Information
  11.1.2 Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered
  11.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Teva Pharmaceuticals Main Business Overview
  11.1.5 Teva Pharmaceuticals Latest Developments
11.2 Hikma Pharmaceuticals
  11.2.1 Hikma Pharmaceuticals Company Information
  11.2.2 Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered
  11.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Hikma Pharmaceuticals Main Business Overview
  11.2.5 Hikma Pharmaceuticals Latest Developments
11.3 Apotex Inc
  11.3.1 Apotex Inc Company Information
  11.3.2 Apotex Inc Imatinib Mesylate Tablets Product Offered
  11.3.3 Apotex Inc Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Apotex Inc Main Business Overview
  11.3.5 Apotex Inc Latest Developments
11.4 Sun Pharmaceutical Industries
  11.4.1 Sun Pharmaceutical Industries Company Information
  11.4.2 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered
  11.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Sun Pharmaceutical Industries Main Business Overview
  11.4.5 Sun Pharmaceutical Industries Latest Developments
11.5 Lupin Limited
  11.5.1 Lupin Limited Company Information
  11.5.2 Lupin Limited Imatinib Mesylate Tablets Product Offered
  11.5.3 Lupin Limited Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Lupin Limited Main Business Overview
  11.5.5 Lupin Limited Latest Developments
11.6 Natco Pharma
  11.6.1 Natco Pharma Company Information
  11.6.2 Natco Pharma Imatinib Mesylate Tablets Product Offered
  11.6.3 Natco Pharma Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Natco Pharma Main Business Overview
  11.6.5 Natco Pharma Latest Developments
11.7 Getwell Oncology
  11.7.1 Getwell Oncology Company Information
  11.7.2 Getwell Oncology Imatinib Mesylate Tablets Product Offered
  11.7.3 Getwell Oncology Imatinib Mesylate Tablets Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Getwell Oncology Main Business Overview
  11.7.5 Getwell Oncology Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Imatinib Mesylate Tablets Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 100 mg
Table 3. Major Players of 400 mg
Table 4. Imatinib Mesylate Tablets Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Table 7. Imatinib Mesylate Tablets Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Table 10. Global Imatinib Mesylate Tablets Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Imatinib Mesylate Tablets Revenue Market Share by Player (2018-2023)
Table 12. Imatinib Mesylate Tablets Key Players Head office and Products Offered
Table 13. Imatinib Mesylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Imatinib Mesylate Tablets Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Imatinib Mesylate Tablets Market Size Market Share by Regions (2018-2023)
Table 18. Global Imatinib Mesylate Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Imatinib Mesylate Tablets Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Imatinib Mesylate Tablets Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Imatinib Mesylate Tablets Market Size Market Share by Country (2018-2023)
Table 22. Americas Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Table 24. Americas Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Table 26. APAC Imatinib Mesylate Tablets Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Imatinib Mesylate Tablets Market Size Market Share by Region (2018-2023)
Table 28. APAC Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Table 30. APAC Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Table 32. Europe Imatinib Mesylate Tablets Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Imatinib Mesylate Tablets Market Size Market Share by Country (2018-2023)
Table 34. Europe Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Table 36. Europe Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Imatinib Mesylate Tablets Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Imatinib Mesylate Tablets
Table 45. Key Market Challenges & Risks of Imatinib Mesylate Tablets
Table 46. Key Industry Trends of Imatinib Mesylate Tablets
Table 47. Global Imatinib Mesylate Tablets Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Imatinib Mesylate Tablets Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Imatinib Mesylate Tablets Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Teva Pharmaceuticals Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 52. Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offered
Table 53. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Teva Pharmaceuticals Main Business
Table 55. Teva Pharmaceuticals Latest Developments
Table 56. Hikma Pharmaceuticals Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 57. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offered
Table 58. Hikma Pharmaceuticals Main Business
Table 59. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Hikma Pharmaceuticals Latest Developments
Table 61. Apotex Inc Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 62. Apotex Inc Imatinib Mesylate Tablets Product Offered
Table 63. Apotex Inc Main Business
Table 64. Apotex Inc Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Apotex Inc Latest Developments
Table 66. Sun Pharmaceutical Industries Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 67. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offered
Table 68. Sun Pharmaceutical Industries Main Business
Table 69. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sun Pharmaceutical Industries Latest Developments
Table 71. Lupin Limited Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 72. Lupin Limited Imatinib Mesylate Tablets Product Offered
Table 73. Lupin Limited Main Business
Table 74. Lupin Limited Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Lupin Limited Latest Developments
Table 76. Natco Pharma Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 77. Natco Pharma Imatinib Mesylate Tablets Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Natco Pharma Latest Developments
Table 81. Getwell Oncology Details, Company Type, Imatinib Mesylate Tablets Area Served and Its Competitors
Table 82. Getwell Oncology Imatinib Mesylate Tablets Product Offered
Table 83. Getwell Oncology Main Business
Table 84. Getwell Oncology Imatinib Mesylate Tablets Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Getwell Oncology Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Imatinib Mesylate Tablets Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Imatinib Mesylate Tablets Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Imatinib Mesylate Tablets Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Imatinib Mesylate Tablets Sales Market Share by Country/Region (2022)
Figure 8. Imatinib Mesylate Tablets Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Imatinib Mesylate Tablets Market Size Market Share by Type in 2022
Figure 10. Imatinib Mesylate Tablets in Hospital
Figure 11. Global Imatinib Mesylate Tablets Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Imatinib Mesylate Tablets in Clinics
Figure 13. Global Imatinib Mesylate Tablets Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Global Imatinib Mesylate Tablets Market Size Market Share by Application in 2022
Figure 15. Global Imatinib Mesylate Tablets Revenue Market Share by Player in 2022
Figure 16. Global Imatinib Mesylate Tablets Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions)
Figure 18. APAC Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions)
Figure 19. Europe Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Imatinib Mesylate Tablets Market Size 2018-2023 ($ Millions)
Figure 21. Americas Imatinib Mesylate Tablets Value Market Share by Country in 2022
Figure 22. United States Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Imatinib Mesylate Tablets Market Size Market Share by Region in 2022
Figure 27. APAC Imatinib Mesylate Tablets Market Size Market Share by Type in 2022
Figure 28. APAC Imatinib Mesylate Tablets Market Size Market Share by Application in 2022
Figure 29. China Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Imatinib Mesylate Tablets Market Size Market Share by Country in 2022
Figure 36. Europe Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Figure 37. Europe Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Figure 38. Germany Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Imatinib Mesylate Tablets Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Imatinib Mesylate Tablets Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 52. APAC Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 53. Europe Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 55. United States Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 56. Canada Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 59. China Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 60. Japan Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 61. Korea Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 63. India Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 64. Australia Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 65. Germany Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 66. France Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 67. UK Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 68. Italy Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 69. Russia Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 70. Spain Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 73. Israel Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Imatinib Mesylate Tablets Market Size 2024-2029 ($ Millions)
Figure 76. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Imatinib Mesylate Tablets Market Size Market Share Forecast by Application (2024-2029)